Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. XOMAO
XOMAO logo

XOMAO

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

XOMAO News

XOMA Royalty Completes Acquisition of Generation Bio

Feb 09 2026Newsfilter

XOMA Corp Announces $0.5234 Dividend for 8.375% DP Preferred Shares

Dec 22 2025SeekingAlpha

XOMA Completes Acquisition of Mural Oncology at $2.035 per Share

Dec 05 2025Newsfilter

XOMA Royalty Announces Financial Results for Q3 and Year-to-Date 2025, Along with Recent Business Milestones

Nov 12 2025Newsfilter

XOMA Royalty Prolongs Tender Offer to Purchase LAVA Therapeutics N.V.

Oct 02 2025Newsfilter

XOMA Royalty Enters into Agreement to Acquire LAVA Therapeutics for Between $1.16 and $1.24 Per Share in Cash, Plus a Contingent Value Right

Aug 04 2025Newsfilter

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

Aug 04 2025Newsfilter

Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right

Jun 27 2025Newsfilter

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Jun 18 2025Newsfilter

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million

May 27 2025Newsfilter

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements

May 13 2025Newsfilter

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

Apr 14 2025Newsfilter

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

Apr 02 2025Newsfilter

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Mar 20 2025Newsfilter

XOMA Royalty Declares Quarterly Preferred Stock Dividends

Dec 19 2024Newsfilter

XOMA Corp - 8.375% DP PFD B declares $0.5234 dividend

Dec 19 2024SeekingAlpha